{"id":251979,"date":"2024-04-30T00:00:00","date_gmt":"2024-04-30T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidhe0023-biopharma-hemophilia-a-epidemiology-epidemiology\/"},"modified":"2026-04-21T11:15:47","modified_gmt":"2026-04-21T11:15:47","slug":"epidhe0023-biopharma-hemophilia-a-epidemiology-epidemiology-dashboard","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidhe0023-biopharma-hemophilia-a-epidemiology-epidemiology-dashboard\/","title":{"rendered":"Hemophilia A &#8211; Epidemiology &#8211; Epidemiology Dashboard"},"content":{"rendered":"<p>Clarivate Epidemiology&#8217;s coverage of Hemophilia A comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the diagnosed prevalence of Hemophilia A for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Most patient populations are forecast over a period of 20 years for the mature markets and Europe, and 10 years for the other countries we cover.<\/p>\n<p>All forecast data are available on Clarivate\u2019s Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>Clarivate Epidemiology&#8217;s Hemophilia A forecast answers the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>How will change in the levels of exposure to known risk or protective factors affect the number of people living with a diagnosis of hemophilia A and the number of new diagnosed?<\/li>\n<li>Of all people diagnosed with hemophilia A, how many in each country across the major mature pharmaceutical markets are drug-treated?<\/li>\n<li>Of all people diagnosed with hemophilia A, how many in each country across the major mature pharmaceutical markets are drug-treated?<\/li>\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of hemophilia A over the forecast period?<\/li>\n<\/ul>\n<p>In addition to the total number of cases for each forecast year, Clarivate Epidemiology provides at least 10 years of forecast data for the following hemophilia A subpopulation:<\/p>\n<ul class=\"round-bullets\">\n<li>Top-line epidemiology: Diagnosed hemophilia A prevalent cases<\/li>\n<li>Diagnosed inhibitor-positive Hemophilia A prevalent cases<\/li>\n<li>Diagnosed prevalent cases by severity<\/li>\n<li>Diagnosed prevalent cases by inhibitor status<\/li>\n<li>Diagnosed inhibitor-positive prevalent cases by inhibitor titre<\/li>\n<li>Drug-Treated Prevalent Cases of Hemophilia A<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country.<\/p>\n","protected":false},"template":"","class_list":["post-251979","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-hematology","biopharma-therapy-areas-hemophilia","biopharma-product-epidemiology","biopharma-date-985"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":3,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251979\/revisions"}],"predecessor-version":[{"id":575969,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251979\/revisions\/575969"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=251979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}